ELEVElevation Oncology, Inc.

Nasdaq elevationoncology.com


$ 3.62 $ -0.02 (-0.69 %)    

Friday, 26-Apr-2024 15:59:39 EDT
QQQ $ 431.01 $ 3.03 (0.71 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.48 (0.55 %)
GLD $ 216.60 $ 0.68 (0.31 %)
$ 3.62
$ 3.69
$ 0.00 x 0
$ 0.00 x 0
$ 3.58 - $ 3.81
$ 0.36 - $ 5.89
1,231,239
na
124.21M
$ 243.78
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-06-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-09-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 03-03-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-elevation-oncology-maintains-6-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Elevation Oncology (NASDAQ:ELEV) with a Buy and maintains ...

 elevation-oncology-presents-preclinical-proof-of-concept-data-for-her3-adc-program-at-aacr-annual-meeting-2024

-- On-track to nominate development candidate in 2024 --BOSTON, April 8, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (NASDAQ:...

Core News & Articles

https://www.hhs.gov/about/news/2024/03/26/hhs-announces-savings-41-prescription-drugs-thanks-inflation-rebates-from-biden-harri...

 jmp-securities-reiterates-market-outperform-on-elevation-oncology-maintains-7-price-target

JMP Securities analyst Silvan Tuerkcan reiterates Elevation Oncology (NASDAQ:ELEV) with a Market Outperform and maintains $7...

 wedbush-maintains-outperform-on-elevation-oncology-raises-price-target-to-8

Wedbush analyst Robert Driscoll maintains Elevation Oncology (NASDAQ:ELEV) with a Outperform and raises the price target fro...

 hc-wainwright--co-reiterates-buy-on-elevation-oncology-maintains-6-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Elevation Oncology (NASDAQ:ELEV) with a Buy and maintains ...

 elevation-oncology-q4-eps-019-beats-023-estimate-cash-cash-equivalents-and-marketable-securities-and-approximately-17m-in-net-proceeds-raised-under-its-atm-facility-is-expected-to-provide-cash-runway-into-fourth-quarter-of-2025

Elevation Oncology (NASDAQ:ELEV) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(...

 elevation-oncology-to-present-preclinical-proof-of-concept-data-for-her3-adc-program-at-the-american-association-for-cancer-research-annual-meeting-2024

Data support ongoing development of antibody-drug conjugate (ADC) program targeting HER3-expressing cancers –-- On-track to nom...

 jmp-securities-initiates-coverage-on-elevation-oncology-with-market-outperform-rating-announces-price-target-of-7

JMP Securities analyst Silvan Tuerkcan initiates coverage on Elevation Oncology (NASDAQ:ELEV) with a Market Outperform ratin...

 hc-wainwright--co-maintains-buy-on-elevation-oncology-raises-price-target-to-6

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Elevation Oncology (NASDAQ:ELEV) with a Buy and raises the ...

 why-aehr-test-systems-shares-are-trading-lower-by-15-here-are-20-stocks-moving-premarket

Shares of Aehr Test Systems (NASDAQ: AEHR) shares fell sharply in pre-market trading after the company lowered its full-year r...

 whats-going-on-with-elevation-oncology-stock

Elevation Oncology, Inc. (NASDAQ: ELEV) shares raced higher Monday. The company announced program updates and upcoming 2024 mil...

 why-rxsight-shares-are-trading-higher-by-20-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION